BioTelemetry (BEAT) Misses Q4 EPS by 1c

BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.05, $0.01 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $43.7 million versus the consensus estimate of $43.4 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• FuelCell Energy signs deal with Fit Energy for up to 380 MW of power
• Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'